ABT-199 (GDC-199)

venetoclax

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-199 (GDC-199), covering 2021-05-11 to 2021-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia [Phase 2]